RDY Dr. Reddy's Laboratories Ltd
$13.75▲ +0.00%
Healthcare
Other
After hours
$13.75▲ +0.00%
Oct 27, 5:05 PM ET
Volume 4.58M
Avg Volume (10D) 3.19M
Key Metrics & Fundamentals
Market Cap
$11.45B
P/E Ratio
38.2
Div Yield
0.61%
52W Range
11.36 - 15.67
% vs 50 MA
10.72%
% vs 200 MA
4.15%
RSI-14
73.9
MACD Histogram
+0.0900
Beta (1Y vs SPY)
0.30
Free Cash Flow
$959.00M
Gross Rev
$86.71B
Gross Profit
$45.20B
EBITDA
$18.92B
COGS
$41.50B
Operating Exp
$32.40B
Operating Income
$12.81B
EBIT
$12.81B
Pretax Income
$12.28B
Net Income
$9.25B
EPS (Diluted)
11.10
Price & Volume History
Loading chart…
Recent News
RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall
Zacks · Oct 26, 2026 10:17 AM ET
Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery in Focus ...
GuruFocus.com · Oct 25, 2026 5:02 AM ET
Dr. Reddy's Laboratories Q2 Earnings Call Highlights
MarketBeat · Oct 23, 2026 2:04 PM ET
Top Stock Reports for Oracle, American Express & Progressive
Zacks · Oct 12, 2026 3:24 PM ET
NBIX vs. TEVA: Which Drugmaker Is the Better Investment?
Zacks · Aug 25, 2026 1:26 PM ET
Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
Business Wire · Aug 4, 2026 1:39 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2026
See RDY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.